Conditions

Meta-analysis found metformin therapy was associated with decreased risk for colorectal adenomas and colorectal cancer among T2 patients.

Insulin resistance is inversely and independently associated with bone size in young men without diabetes, according to a new study.

CV data added to labels for treatments containing empagliflozin.

Can we answer the question of how you can have a pre-disease that increases your risk of death? You either have it or you don’t!

Barrier means more work including monitoring more often and making more adjustments.

Dr. Altamash Shaikh talks with Diabetes in Control Associate Medical Editor Joy Pape at the 2016 AACE Meeting. In part 1 of this Exclusive Interview, Dr. Shaikh explains the current state of diabetes in India and the needs required to help this population to manage this condition.

Study data show fasting glucose concentrations of at least 100 mg/dL (5.6 mmol/L) or an HbA1c of at least 5.7% (39 mmol/mol) were determining factors.

Liraglutide, on top of stable renin angiotensin system (RAS)-inhibition, is associated with significant reduction in albuminuria among patients with type 2 diabetes and persistent microalbuminuria.

Study offers at least partial explanation for opposing findings between previous observational studies.

Therapy shows neutral CV benefit, increases bleeding risk in type 2 diabetes.